Sarepta Therapeutics (SRPT) and Genethon Enter Gene Therapy Research Collaboration Targeting Duchenne MD – StreetInsider.com
FierceBiotech |
Sarepta Therapeutics (SRPT) and Genethon Enter Gene Therapy Research Collaboration Targeting Duchenne MD
StreetInsider.com Sarepta Therapeutics, Inc. (NASDAQ:S RPT) and Genethon, a non-profit R&D organization dedicated to the development of biotherapies for orphan genetic diseases from research to clinical validation, have signed a gene therapy research collaboration to … Sarepta signs another Duchenne gene therapy pact as it aims for wider treatment Sarepta and Genethon Collaborate on Gene Therapy Research for Duchenne Sarepta to collaborate with Genethon on DMD gene therapy; Chinese investors pull back on Pluristem investment |
